Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 05-Nov-2017

Phoenix Nest, Inc.


Phoenix Nest Inc. collaborates with academic researchers to help them fund and commercialize their technologies for Sanfilippo Syndrome IIIB, IIIC and IIID which are fatal neurological diseases. Phoenix Nest is developing an ERT for MPS IIID developed at LABioMed which can be given intrathecally. This is the simplest and most efficient method to treat the underlying causes of the neurologic symptoms that dominate pathology. As the enzyme is similar to that naturally occurring in humans adverse events are not expected. We currently have a patent pending that would last for over a decade


Original YouTube URL: Open

Introduction Video

Additional Questions

Who is your customer?

Rare disease patients with Sanfilippo Syndrome.

What problem does this idea/product solve or what market need does it serve?

Treatments for a devasting, fatal rare disease.

What attributes will make this idea/product successful? Why do you believe that those features will create success?

Company founded by a parent of a child with the disease and a scientist with a passion for rare diseases.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

We have leveraged NIH funding to fund the company completely. Our ability to leverage these funding sources is essential.